The conference report from the European Alliance of Personalised Medicine, 27-28 March has been released.

The over-arching theme for this fifth EAPM conference, under the auspices of the Maltese Presidency of the European Union, was lung-cancer screening.

The conference, entitled ‘Innovation, Guidelines and Screening: The Case of Lung Cancer’ took a close look at lung-cancer screening, although its general subject matter was much broader, focusing on many of the issues that affect personalised medicine today.

A core working group (consisting of certain conference speakers) has been set up to develop the issues arising in this report. 

This is in order to drive forward and implement the outcomes into policy recommendations at EU, national and local level.

To support this common effort, a white paper will be published in the coming months to coincide with a consensus document setting out the
mechanisms and rationale for implementation.

Meanwhile, this report has been set out in a narrative style so as to more easily capture the diversity of presentations and discussions.

If you have questions regarding the points set out in the report, please do let us know.

The issues set out in the report will also be discussed in the EAPM Congress entitled Personalising Your Health: A Global Imperative' taking place on Nov. 27 - 30. 

ecancer will be filming interviews with key speakers at the Congress, which you can keep up to date with here.

Source: EAPM